Alignment Healthcare, Inc. Ratios | P/E, ROE & Valuation

On the Key Ratios page for Alignment Healthcare, Inc. (ALHC), the latest P/E of 41.6 frames valuation, while ROE 20.02% and ROIC 9.23% indicates profitability and capital efficiency. Together with the current ratio of 1.70 and debt-to-equity 1.25, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

ALHC Historical Per Share Metrics

7 years
Metric (FY)TTM202420232022202120202019
Revenue per Share$22.06$14.17$9.79$7.91$6.79$5.12$4.98
Net Income per Share$0.20$-0.67$-0.79$-0.83$-1.14$-0.12$-0.29
Operating Cash Flow per Share$0.99$0.18$-0.32$-0.25$-0.46$0.04$0.06
Free Cash Flow per Share$0.99$-0.03$-0.51$-0.38$-0.56$-0.04$-0.01
Cash per Share$3.38$2.47$1.71$2.26$2.71$1.11$0.57
Book Value per Share$1.28$0.53$0.85$1.32$1.78$0.16$-0.52
Tangible Book Value per Share$1.10$0.32$0.63$1.10$1.58$-0.02$-0.75
Interest Debt per Share$1.67$1.85$1.03$1.01$1.02$0.92$1.00
CAPEX per Share$0.00$0.22$0.19$0.13$0.11$0.08$0.07

ALHC Historical Valuation Ratios

7 years
Metric (FY)TTM202420232022202120202019
Price to Earnings (P/E)41.6-16.76-10.83-14.25-12.38-141.4-58.87
Price to Book (P/B)6.4921.510.228.957.9105.9-33.46
Price to Sales (P/S)0.380.790.881.492.073.383.48
Enterprise Value to EBITDA15.7-26.38-14.92-16.61-13.03336.87-202.6
EV to Sales0.30.760.861.321.813.323.55
EV to Operating Cash Flow6.6158.75-26.55-41.52-26.77421.75291.58
EV to Free Cash Flow6.61-307.29-16.51-27.26-21.71-391.41-2589.09
Enterprise Value$1.36B$2.04B$1.57B$1.89B$2.11B$3.19B$2.68B

ALHC Historical Profitability Ratios

7 years
Metric (FY)TTM202420232022202120202019
Return on Equity (ROE)20.02%-128.23%-94.31%-62.80%-63.81%-74.89%56.83%
Return on Invested Capital (ROIC)9.23%-23.54%-38.86%-31.92%-38.41%-2.84%-46.66%
Return on Tangible Assets3.28%-17.24%-26.82%-25.19%-32.78%-7.54%-28.23%
Earnings Yield2.36%-5.97%-9.23%-7.02%-8.08%-0.71%-1.70%
Free Cash Flow Yield11.94%-0.31%-5.94%-3.25%-4.02%-0.25%-0.04%
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%

ALHC Historical Liquidity & Financial Strength

7 years
Metric (FY)TTM202420232022202120202019
Current Ratio1.71.881.842.373.311.720.98
Interest Coverage3.39-4.31-6.02-7.03-10.21-0.31-1.98
Income Quality5.05-0.270.40.30.4-0.33-0.21
Debt to Equity1.253.31.090.690.515.05-1.75
Debt to Assets25.84%42.10%28.86%25.97%24.98%45.62%71.32%
Net Debt to EBITDA-4.191.340.312.161.91-5.59-3.88

ALHC Historical Efficiency Ratios

7 years
Metric (FY)TTM202420232022202120202019
Receivables Turnover15.4217.5715.2315.4419.9623.921.24
Payables Turnover9.679.939.547.2759.616.185.62
Inventory Turnover0000000
Days Sales Outstanding23.6720.7823.9723.6418.2915.2717.18
Days Payables Outstanding37.7336.7738.2650.216.1259.0464.97
Days of Inventory on Hand0000000

ALHC Historical Market Metrics

7 years
Metric (FY)TTM202420232022202120202019
Enterprise Value to EBITDA15.7-26.38-14.92-16.61-13.03336.87-202.6
Market Cap$1.72B$2.15B$1.60B$2.13B$2.42B$3.24B$2.63B
Enterprise Value$1.36B$2.04B$1.57B$1.89B$2.11B$3.19B$2.68B
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Payout Ratio0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

How does Alignment Healthcare, Inc.’s P/E ratio compare with its history?

On this page, ALHC's current P/E is 41.6, compared with a multi-year average around 41.6. When the current P/E sits near its historical average, the multiple is close to that range. Look at trend direction in profitability and cash-flow rows, plus liquidity and leverage, rather than treating the P/E in isolation.

What is Alignment Healthcare, Inc. market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The latest market cap shown in the table is $1.72B. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

How does Alignment Healthcare, Inc.’s P/E compare with its industry?

There is no P/E Tickerplace rates as good. Compare the P/E on this page with Alignment Healthcare, Inc.'s own historical range (in the table) and with peers via the Screener and Compare tools. A higher or lower multiple versus peers is a calculated gap, not a recommendation.

How does Alignment Healthcare, Inc. compare to its competitors in key financial ratios?

The fastest way to compare Alignment Healthcare, Inc. with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see Alignment Healthcare, Inc. outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

What do Alignment Healthcare, Inc.'s liquidity and leverage ratios show?

Liquidity and leverage figures on this page are published ratios, not a verdict that Alignment Healthcare, Inc. is financially strong. Current ratio is about 1.70, which is above 1.0 and can indicate more comfortable short-term liquidity. Interest coverage is about 3.39, implying a stronger ability to cover interest expenses. Debt-to-equity is about 1.25, suggesting leverage is more moderate relative to a high-debt profile. Pair them with ROE/ROIC and cash-flow rows in the table. Tickerplace does not rate the company as a good or poor investment.

What do Alignment Healthcare, Inc.'s financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If Alignment Healthcare, Inc. is sustaining strong returns (for example ROE at 20.02% and ROIC at 9.23%) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.